Showing results (1-10 of 218) with videos related to
Sort By:
Pageof 22
Expert Review of Anticancer Therapy|March 11, 2010
Unresolved issues in diffuse large B-cell lymphomasNiels Murawski, Carsten Zwick, Michael PfreundschuhSeminars in Hematology|March 31, 2010
Rituximab in high-grade lymphomaCarsten Zwick, Niels Murawski, Michael Pfreundschuh, et al.International Journal of Cancer|February 14, 2015
CD4⁺ T cells in chronic autoantigenic stimulation in MGUS, multiple myeloma and Waldenström's macroglobulinemiaFrank Neumann, Michael Pfreundschuh, Klaus D Preuss, et al.The Lancet. Oncology|November 6, 2010
New drugs for aggressive B-cell and T-cell lymphomasNiels Murawski, Michael PfreundschuhClinical Lymphoma & Myeloma|March 8, 2008
Aspects of chemotherapy schedules in young and elderly patients with aggressive lymphomaCarsten Zwick, Beate Gleissner, Michael PfreundschuhHuman Gene Therapy|September 13, 2012
Mutated Ras-transfected, EBV-transformed lymphoblastoid cell lines as a model tumor vaccine for boosting T-cell responses against pancreatic cancer: a pilot trialBoris Kubuschok, Michael Pfreundschuh, Rainer Breit, et al.Blood|December 4, 2013
Suboptimal dosing of rituximab in male and female patients with DLBCLMichael Pfreundschuh, Carsten Müller, Samira Zeynalova, et al.Immunological Reviews|November 26, 2002
Analysis of the B-cell repertoire against antigens expressed by human neoplasmsKlaus-Dieter Preuss, Carsten Zwick, Claudia Bormann, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2014
Role of radiotherapy to bulky disease in elderly patients with aggressive B-cell lymphomaGerhard Held, Niels Murawski, Marita Ziepert, et al.Blood|June 19, 2014
The role of radiotherapy and intrathecal CNS prophylaxis in extralymphatic craniofacial aggressive B-cell lymphomasNiels Murawski, Gerhard Held, Marita Ziepert, et al.Pageof 22